Physician profile
Brian Glen Mitchell
NPI 1427240811
$1,192.66
in general payments reported to CMS, 2019-2025
12 companies · $280 in 2025
The $280 reported for 2025 was more than what 82% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $24.90 · 2021: $35.31 · 2022: $141 · 2023: $432 · 2024: $280 · 2025: $280.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $992.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $991.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nobel Biocare USA | $293.58 | 2023 | Nobelactive |
| Align Technology, INC. | $267.66 | 2023-2025 | Invisalign |
| Patterson Companies, INC. | $136.91 | 2023-2025 | |
| Biolase, INC. | $128.83 | 2022 | |
| Dentsply Sirona INC | $127.62 | 2024 | Astra Tech Implant System |
| Henry Schein, INC. | $84.81 | 2024 | 3shape Trios A/S-Trios3 Pen W/Move+ |
| 3m Company | $42.48 | 2020-2021 | |
| Orapharma, A Division of Bausch Health US, LLC | $39.54 | 2025 | Arestin |
| Solventum Corporation | $25.45 | 2024 | 3m Relyx |
| Zimmer Biomet Holdings, INC. | $17.73 | 2021 | |
| Straumann USA LLC | $16.37 | 2023 | |
| Ultradent Products INC | $11.68 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Mitchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.